ZYVERSA THERAPEUTICS, INC. (ZVSA) Operating income 2023–2025
ZYVERSA THERAPEUTICS, INC. (ZVSA) annual operating income history from SEC filings — each fiscal year as reported.
-$25.5MFY2025 · since FY2023: -$107.8M → -$25.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.5M | -179.0% |
| FY2024 | -$9.1M | +91.5% |
| FY2023 | -$107.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVSA financial trends
ZVSA RevenueZVSA Net incomeZVSA Net marginZVSA Gross profitZVSA Gross marginZVSA Operating marginZVSA Operating cash flowZVSA Free cash flowZVSA Capital expendituresZVSA Return on equityZVSA Stock buybacksZVSA Dividends paidZVSA Total assetsZVSA Total liabilitiesZVSA Shareholders’ equityZVSA overview →